Prostaglandin E2: From Clinical Applications to Its Potential Role in Bone- Muscle Crosstalk and Myogenic Differentiation
Author(s): Chenglin Mo, Sandra Romero-Suarez, Lynda Bonewald, Mark Johnson, Marco Brotto	Muscle Biology Research Group-MUBIG, School of Nursing, University of Missouri-Kansas, Health Sciences Building 2246, Kansas City, MO, 64108, USA.
Journal Name: Recent Patents on Biotechnology
DOI : 10.2174/1872208311206030223
Prostaglandin E2 (PGE2), a prostanoid synthesized from arachidonic acid via the cyclooxygenase pathway, is a modulator of physiological responses including inflammation, fever, and muscle regeneration. Several patents have been filed that are related to PGE2, one of them being directly related to skeletal muscles. In this report, we first summarize the key patents describing inventions for the utilization of PGE2 for either diagnostic or therapeutic purposes, including skeletal muscle. In the second part of our work we present new and exciting data that demonstrates that PGE2 accelerates skeletal muscle myogenic differentiation. Our discovery resulted from our recent and novel concept of bone-muscle crosstalk. Bone and muscle are anatomically intimate endocrine organs and we aimed to determine whether this anatomical intimacy also translates into a biochemical communication from bone cells to muscle cells at the in vitro level. The effects of MLOY4 osteocyte-like cell conditioned medium (CM) and three osteocyte-secreted factors, PGE2, sclerostin and monocyte chemotactic protein (MCP-3), on C2C12 myogenic differentiation were evaluated using morphological analyses, a customized 96-gene PCR array, and measurements of intracellular calcium levels. MLO-Y4 CM and PGE2, but not sclerostin and MCP-3, induced acceleration of myogenesis of C2C12 myoblasts that was linked with significant modifications in intracellular calcium homeostasis. This finding should further stimulate the pursuit of new patents to explore the use of PGE2 and the new concept of bone-muscle crosstalk for the development and application of inventions designed to treat muscle diseases characterized by enhanced muscle wasting, such as sarcopenia.
Keywords: Bone-muscle crosstalk, PGE2, inventions, prostaglandins, prostanoid, EP Receptors, gene expression, MyoD, muscle regulatory factors, myogenic acceleration, calcium release, excitation-contraction coupling, bone cells, osteocytes, MLO-Y4 osteocytes-like cells, MLO-Y4 conditioned media, bone secreted factors, muscle secreted factors, myokines, calcium-induced calcium release (CICR), patents
Title:Prostaglandin E2: From Clinical Applications to Its Potential Role in Bone- Muscle Crosstalk and Myogenic Differentiation
Author(s):Chenglin Mo, Sandra Romero-Suarez, Lynda Bonewald, Mark Johnson and Marco Brotto
Affiliation:Muscle Biology Research Group-MUBIG, School of Nursing, University of Missouri-Kansas, Health Sciences Building 2246, Kansas City, MO, 64108, USA.
Keywords:Bone-muscle crosstalk, PGE2, inventions, prostaglandins, prostanoid, EP Receptors, gene expression, MyoD, muscle regulatory factors, myogenic acceleration, calcium release, excitation-contraction coupling, bone cells, osteocytes, MLO-Y4 osteocytes-like cells, MLO-Y4 conditioned media, bone secreted factors, muscle secreted factors, myokines, calcium-induced calcium release (CICR), patents
Abstract:Prostaglandin E2 (PGE2), a prostanoid synthesized from arachidonic acid via the cyclooxygenase pathway, is a modulator of physiological responses including inflammation, fever, and muscle regeneration. Several patents have been filed that are related to PGE2, one of them being directly related to skeletal muscles. In this report, we first summarize the key patents describing inventions for the utilization of PGE2 for either diagnostic or therapeutic purposes, including skeletal muscle. In the second part of our work we present new and exciting data that demonstrates that PGE2 accelerates skeletal muscle myogenic differentiation. Our discovery resulted from our recent and novel concept of bone-muscle crosstalk. Bone and muscle are anatomically intimate endocrine organs and we aimed to determine whether this anatomical intimacy also translates into a biochemical communication from bone cells to muscle cells at the in vitro level. The effects of MLOY4 osteocyte-like cell conditioned medium (CM) and three osteocyte-secreted factors, PGE2, sclerostin and monocyte chemotactic protein (MCP-3), on C2C12 myogenic differentiation were evaluated using morphological analyses, a customized 96-gene PCR array, and measurements of intracellular calcium levels. MLO-Y4 CM and PGE2, but not sclerostin and MCP-3, induced acceleration of myogenesis of C2C12 myoblasts that was linked with significant modifications in intracellular calcium homeostasis. This finding should further stimulate the pursuit of new patents to explore the use of PGE2 and the new concept of bone-muscle crosstalk for the development and application of inventions designed to treat muscle diseases characterized by enhanced muscle wasting, such as sarcopenia.
Chenglin Mo, Sandra Romero-Suarez, Lynda Bonewald, Mark Johnson and Marco Brotto, "Prostaglandin E2: From Clinical Applications to Its Potential Role in Bone- Muscle Crosstalk and Myogenic Differentiation", Recent Patents on Biotechnology (2012) 6: 223. https://doi.org/10.2174/1872208311206030223
https://doi.org/10.2174/1872208311206030223 Print ISSN
Published on: 06 November, 2012
Highly Resolution of Propranolol Using Oxidized Multi-walled Carbon Nanotubes and β-cyclodextrin Derivatives as Impregnating Reagents
Renal Effects of Non-Steroidal Anti-Inflammatory Drugs and Selective Cyclooxygenase-2 Inhibitors
Clinical Profile of Eprosartan: A Different Angiotensin II Receptor Blocker
Cardiovascular & Hematological Agents in Medicinal Chemistry
Cardiovascular Effects of Liraglutide
Current Hypertension Reviews
An Overview of Hepatoprotective Effects of Thymoquinone
Recent Patents on Food, Nutrition & Agriculture
A Review on the Development in the Field of NIDDM based Thiazolidinedione PPARγ Agonists
Mini-Reviews in Medicinal Chemistry
MDMA Administration and Heat Shock Proteins Response: Foreseeing a Molecular Link
Current Treatment Strategies for Hepatocellular Carcinoma
Current Cancer Therapy Reviews
Immunomodulation in Inflammatory Neuropathies: Rationale and Safety
Evaluation of the Effects of 1,25 Vitamin D3 on Regulatory T Cells and T Helper 17 Cells in Vitamin D-deficient Women with Unexplained Recurrent Pregnancy Loss
Recent Patents on the Baculovirus Systems
Plasticity and Maintenance of Hematopoietic Stem Cells During Development
Bioprospecting of Brevibacillus brevis Isolated from Soil
Construction and Cloning of Plastic-degrading Recombinant Enzymes (MHETase)
Recent Patents on the Industrial Application of Alpha-amylases
Designing an Outer Membrane Protein (Omp-W) Based Vaccine for Immunization against Vibrio and Salmonella: An in silico Approach
Lipases: Sources, Production, Purification, and Applications
Monoclonal Antibodies as Cancer Therapeutics
Food Biotechnology: A Step Towards Improving Nutritional Quality of Food for Asian Countries